Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis and vitamin D: an update.

B M VanAmerongen1, C D Dijkstra, P Lips

  • 1Department of Molecular Cell Biology and Immunology, VU Medical Center, Amsterdam, The Netherlands. b.m.van.amerongen@inter.nl.net

European Journal of Clinical Nutrition
|April 1, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.

AJNR. American journal of neuroradiology·2016
Same author

Enhanced axonal metabolism during early natalizumab treatment in relapsing-remitting multiple sclerosis.

AJNR. American journal of neuroradiology·2015
Same author

Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy.

Multiple sclerosis (Houndmills, Basingstoke, England)·2014
Same author

Detecting clinically-relevant changes in progressive multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2014
Same author

The helminth Trichuris suis suppresses TLR4-induced inflammatory responses in human macrophages.

Genes and immunity·2014
Same author

Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.

Journal of neurology, neurosurgery, and psychiatry·2014
Same journal

Association between nutrition knowledge and Mediterranean diet adherence in Israeli adults with type 2 diabetes.

European journal of clinical nutrition·2026
Same journal

Evaluation of a context-specific diet diversity score (DDS) for predicting micronutrient adequacy in 6-10-year-old rural Indian children.

European journal of clinical nutrition·2026
Same journal

Beyond reliability: Addressing systematic bias and advancing standardization in bioelectrical impedance analysis.

European journal of clinical nutrition·2026
Same journal

Efficacy and safety of hydrolyzed collagen supplementation on skin health outcomes: a systematic literature review of randomized controlled trials.

European journal of clinical nutrition·2026
Same journal

Fermented foods and inflammation: a crossover intervention trial with fresh and pasteurized sauerkraut.

European journal of clinical nutrition·2026
Same journal

Comparative machine learning modeling of resting energy expenditure estimation in mechanically ventilated children after cardiac surgery.

European journal of clinical nutrition·2026
See all related articles

Vitamin D may help manage multiple sclerosis (MS) by regulating immune responses and reducing inflammation. Maintaining optimal vitamin D levels may also prevent MS complications like bone loss and muscle weakness.

Area of Science:

  • Neuroimmunology
  • Endocrinology
  • Immunology

Background:

  • Multiple Sclerosis (MS) is a chronic, immune-mediated CNS disease with unknown etiology.
  • MS prevalence correlates inversely with environmental vitamin D availability.
  • The active form of vitamin D, 1,25-dihydroxyvitamin D (1,25-(OH)(2)D), exhibits immunoregulatory and anti-inflammatory properties.

Purpose of the Study:

  • To investigate the role of vitamin D in modulating immune responses relevant to MS.
  • To explore the therapeutic potential of 1,25-(OH)(2)D in experimental models of MS.

Main Methods:

  • Review of existing literature on vitamin D metabolism and its effects on immune cells.
  • Analysis of studies involving administration of 1,25-(OH)(2)D in animal models of MS (EAE).

Related Experiment Videos

  • Examination of the impact of vitamin D on dendritic cells, T-cells, and macrophages.

    • Main Results:

    • 1,25-(OH)(2)D administration in EAE models prevented and reduced disease activity.
    • Vitamin D metabolite influences dendritic cell and T-cell function and regulates macrophages.
    • Potential direct effects of 1,25-(OH)(2)D on CNS cells are suggested.

    Conclusions:

    • Vitamin D deficiency, due to low intake or sunlight exposure, may contribute to MS risk.
    • Optimal serum 25OHD concentrations may suppress MS disease activity.
    • Adequate vitamin D may mitigate MS-related complications such as bone resorption and muscle weakness.